Dennis Asharin - Bausch Lomb Ex Officer
| BLCO Stock | USD 19.67 0.10 0.51% |
Insider
Dennis Asharin is Ex Officer of Bausch Lomb Corp
| Address | 520 Applewood Crescent, Vaughan, ON, Canada, L4K 4B4 |
| Phone | (905) 695-7700 |
| Web | https://www.bausch.com |
Bausch Lomb Management Efficiency
As of the 26th of November 2024, Return On Tangible Assets is likely to grow to -0.05. In addition to that, Return On Capital Employed is likely to drop to 0.01. At this time, Bausch Lomb's Intangibles To Total Assets are very stable compared to the past year. As of the 26th of November 2024, Debt To Assets is likely to grow to 0.36, while Total Assets are likely to drop about 12.8 B. Bausch Lomb's management efficiency ratios could be used to measure how well Bausch Lomb manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Showing other executives | INSIDER Age | ||
| Robert Segura | West Pharmaceutical Services | N/A | |
| Kevin Thornal | Hologic | 50 | |
| Clifford Hoyt | Akoya Biosciences | N/A | |
| Troy Kirkpatrick | Becton Dickinson and | N/A | |
| Karen May | Alcon AG | 61 | |
| Kimberly Martin | Alcon AG | 49 | |
| Antoine Ezell | Becton Dickinson and | 51 | |
| Yury Goltsev | Akoya Biosciences | N/A | |
| R Eckert | Becton Dickinson and | 59 | |
| Nikolay Samusik | Akoya Biosciences | N/A | |
| Marilee MBA | Akoya Biosciences | 65 | |
| Vered Keisar | ResMed Inc | N/A | |
| FACC MD | Becton Dickinson and | N/A | |
| Brian Bonnell | ICU Medical | 50 | |
| Mike Kelly | Hologic | N/A | |
| Margaret Buckley | Alcon AG | N/A | |
| Francesca DeMartino | Becton Dickinson and | N/A | |
| Samrat Esq | Becton Dickinson and | 57 | |
| Carrie Byington | Becton Dickinson and | 57 | |
| Candace Matthews | AptarGroup | 61 | |
| Richard Luzzi | West Pharmaceutical Services | 72 | |
Management Performance
| Return On Equity | -0.0523 | ||||
| Return On Asset | 0.0089 |
Bausch Lomb Corp Leadership Team
Elected by the shareholders, the Bausch Lomb's board of directors comprises two types of representatives: Bausch Lomb inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Bausch. The board's role is to monitor Bausch Lomb's management team and ensure that shareholders' interests are well served. Bausch Lomb's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Bausch Lomb's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Joseph Gordon, Surgical Consumer | ||
| Osama Eldessouky, Executive CFO | ||
| Frederick Munsch, Controller VP | ||
| Asli Gevgilili, Executive Officer | ||
| Christina Ackermann, Gen VP | ||
| Dennis Asharin, Ex Officer | ||
| Yehia MD, Executive officer | ||
| Brenton JD, CEO Chairman | ||
| A Bailey, Executive Officer | ||
| Louis Yu, Ex Officer | ||
| Joseph Papa, CEO Director | ||
| T Crawford, Chief Officer | ||
| Kelly Webber, Ex Officer | ||
| Jonathon Kellerman, Chief Officer | ||
| Manisha Narasimhan, Chief Officer | ||
| Andrew Stewart, President Consumer | ||
| MBA CPFA, Executive Officer |
Bausch Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Bausch Lomb a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -0.0523 | ||||
| Return On Asset | 0.0089 | ||||
| Profit Margin | (0.08) % | ||||
| Operating Margin | 0.05 % | ||||
| Current Valuation | 11.02 B | ||||
| Shares Outstanding | 352.16 M | ||||
| Shares Owned By Insiders | 88.46 % | ||||
| Shares Owned By Institutions | 10.91 % | ||||
| Number Of Shares Shorted | 1.12 M | ||||
| Price To Earning | 39.08 X |
Pair Trading with Bausch Lomb
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Bausch Lomb position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Bausch Lomb will appreciate offsetting losses from the drop in the long position's value.Moving against Bausch Stock
| 0.85 | FORA | Forian Inc | PairCorr |
| 0.74 | IVP | Inspire Veterinary | PairCorr |
| 0.6 | AMN | AMN Healthcare Services | PairCorr |
| 0.57 | AGL | agilon health Buyout Trend | PairCorr |
| 0.54 | EVH | Evolent Health | PairCorr |
The ability to find closely correlated positions to Bausch Lomb could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Bausch Lomb when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Bausch Lomb - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Bausch Lomb Corp to buy it.
The correlation of Bausch Lomb is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Bausch Lomb moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Bausch Lomb Corp moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Bausch Lomb can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Bausch Lomb Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators. You can also try the Portfolio Suggestion module to get suggestions outside of your existing asset allocation including your own model portfolios.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Bausch Lomb. If investors know Bausch will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Bausch Lomb listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.89) | Earnings Share (1.04) | Revenue Per Share 13.327 | Quarterly Revenue Growth 0.188 | Return On Assets 0.0089 |
The market value of Bausch Lomb Corp is measured differently than its book value, which is the value of Bausch that is recorded on the company's balance sheet. Investors also form their own opinion of Bausch Lomb's value that differs from its market value or its book value, called intrinsic value, which is Bausch Lomb's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Bausch Lomb's market value can be influenced by many factors that don't directly affect Bausch Lomb's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Bausch Lomb's value and its price as these two are different measures arrived at by different means. Investors typically determine if Bausch Lomb is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Bausch Lomb's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.